Zenlabs Ethica bulk deals, insider trading and stake changes
BSE: 530697Commercial Services & SuppliesSmall Cap
Zenlabs Ethica Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1995
Last close ₹25.00down ₹1.18 (4.51%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹26.18.
30 Oct: open ₹27.00, high ₹27.00, low ₹25.00
52-week range of traded prices to 30 Oct 2026
₹16.50Low, 24 Mar 2026₹39.99High, 27 May 2026
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹16 Cr4,313th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −26.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.08 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −4.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.22
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,818
Zenlabs Ethica's insiders have 33 trade disclosures on record, the latest on 23 Mar 2024. Its promoter group made no purchase or sale on the market in the 12 months to 30 Oct 2026.
Zenlabs Ethica insider trading
The company's own latest disclosure on record is from Mar 2024.Insider trading, all companies
Mar 2024
- PREET REMEDIES LIMITED₹2.09 Cr4,00,000 sharesGave · Promoter · 22 Mar 2024 · disclosed 23 Mar · Off Market · held 21,30,455 before, holds 17,30,455 after
Oct 2022
- PREET REMEDIES LIMITED₹0.34 Cr45,001 sharesSold · Promoter · 21 Oct 2022 · disclosed 9 Nov · stake 34.12% before, 33.43% after
Sep 2022
- PREET REMEDIES LIMITED₹0.19 Cr30,000 sharesSold · Promoter · 7 Sep 2022 · disclosed 9 Sep · stake 34.58% before, 34.12% after
Aug 2022
- PREET REMEDIES LIMITED₹0.32 Cr57,253 sharesSold · Promoter · 29 Aug 2022 · disclosed 31 Aug · stake 35.46% before, 34.58% after
- PREET REMEDIES LIMITED₹0.26 Cr56,518 sharesSold · Promoter · 22 Aug 2022 · disclosed 24 Aug · stake 36.33% before, 35.46% after
- PREET REMEDIES LIMITED₹15,844349 sharesBought · Promoter · 16 Aug 2022 · disclosed 18 Aug · stake 36.57% before, 36.58% after
- PREET REMEDIES LIMITED₹0.07 Cr16,380 sharesSold · Promoter · 16 Aug 2022 · disclosed 18 Aug · stake 36.58% before, 36.33% after
Jun 2022
- PREET REMEDIES LIMITED₹0.09 Cr21,029 sharesSold · Promoter · 28 Jun 2022 · disclosed 18 Aug · stake 36.90% before, 36.57% after
- PREET REMEDIES LIMITED₹0.24 Cr50,000 sharesSold · Promoter · 24 Jun 2022 · disclosed 25 Jun · stake 37.66% before, 36.90% after
- PREET REMEDIES LIMITED₹0.31 Cr75,000 sharesSold · Promoter · 22 Jun 2022 · disclosed 24 Jun · stake 38.82% before, 37.66% after
- PREET REMEDIES LIMITED₹0.27 Cr72,310 sharesSold · Promoter · 10 Jun 2022 · disclosed 20 Jun · stake 39.93% before, 38.82% after
- Preet Remedies Ltd₹0.27 Cr72,310 sharesGave · Promoter · 10 Jun 2022 · disclosed 20 Jun · Market · stake 39.93% before, 38.82% after
Apr 2022
- PREET REMEDIES LIMITED₹0.26 Cr82,690 sharesSold · Promoter · 20 Apr 2022 · disclosed 2 Jun · stake 41.20% before, 39.93% after
Nov 2021
2 entries
- PREET REMEDIES LIMITED₹2.40 Cr6,77,957 sharesReceived · Promoter · 22 Nov 2021 · disclosed 24 Nov · Inter-se-Transfer · stake 30.78% before, 41.19% after
- HARPREET SINGH₹2.40 Cr6,77,957 sharesGave · Promoter · 22 Nov 2021 · disclosed 24 Nov · Inter-se-Transfer · held 6,77,957 before, holds none after
Aug 2021
3 entries
- SATISH KUMAR₹1.28 Cr3,59,000 sharesGave · Promoter · 11 Aug 2021 · disclosed 12 Aug · Inter-se-Transfer · held 3,59,000 before, holds none after
- SANJAY DHIR₹0.64 Cr1,79,500 sharesReceived · Promoter · 11 Aug 2021 · disclosed 12 Aug · Inter-se-Transfer · stake 10.42% before, 13.18% after
- SANJEEV KUMAR₹0.64 Cr1,79,500 sharesReceived · Promoter · 11 Aug 2021 · disclosed 12 Aug · Inter-se-Transfer · stake 10.42% before, 13.17% after
Sep 2019
2 entries
- Harpreet Singh Kaira1,000sharesGave · Promoter · 17 Sep 2019 · disclosed 18 Sep · Off Market Gift · stake 10.43% before, 10.41% after
- Jasbir Singh Kaira1,000sharesReceived · Promoter · 17 Sep 2019 · disclosed 18 Sep · Off Market Gift · holds 1,000 after
Aug 2019
4 entries
- Harjinder Kaur1,000sharesReceived · Promoter Group · 22 Aug 2019 · disclosed 23 Aug · Off Market Gift · holds 1,000 after, stake 0.01% after
- Himjyoti1,000sharesReceived · Director · 22 Aug 2019 · disclosed 23 Aug · Off Market Gift · holds 1,000 after, stake 0.01% after
- Sanjay Dhir1,000sharesGave · KMP · 22 Aug 2019 · disclosed 23 Aug · Off Market Gift · stake 10.43% before, 10.43% after
- Sanjeev Kumar Singal1,000sharesGave · KMP · 22 Aug 2019 · disclosed 23 Aug · Off Market Gift · stake 10.43% before, 10.43% after
Oct 2018
1 entry
- BonusEvery 20 shares became 21 on 11 Oct 2018. The lines below are on the share count before it.
Mar 2017
5 entries
- Preet Remedies Pvt Ltd₹0.94 Cr3,00,000 sharesReceived · Promoter · 20 Mar 2017 · disclosed 21 Mar · Off Market / Inter se transfer · stake 26.01% before, 30.84% after
- Satish Kumar₹0.14 Cr45,000 sharesGave · Promoter & Director · 20 Mar 2017 · disclosed 21 Mar · Off Market / Inter se transfer · stake 6.24% before, 5.52% after
- Sanjay Dhir₹0.27 Cr85,000 sharesGave · Promoter & Director · 20 Mar 2017 · disclosed 21 Mar · Off Market / Inter se transfer · stake 11.80% before, 10.42% after
- Sanjeev Kumar Singal₹0.27 Cr85,000 sharesGave · Promoter & Director · 20 Mar 2017 · disclosed 21 Mar · Off Market / Inter se transfer · stake 11.80% before, 10.42% after
- Harpreet Singh Karla₹0.27 Cr85,000 sharesGave · Promoter & Director · 20 Mar 2017 · disclosed 21 Mar · Off Market / Inter se transfer · stake 11.80% before, 10.42% after
Jan 2016
4 entries
- Harpreet Singh Karla₹0.73 Cr7,31,626 sharesReceived · Promoter · 2 Jan 2016 · Preferential Offer · holds 7,31,626 after
- Sanjay Dhir₹0.73 Cr7,31,884 sharesReceived · Promoter · 2 Jan 2016 · Preferential Offer · holds 7,31,884 after
- Sanjeev Kumar₹0.73 Cr7,31,626 sharesReceived · Promoter · 2 Jan 2016 · Preferential Offer · holds 7,31,626 after
- Satish Kumar₹0.39 Cr3,87,378 sharesReceived · Promoter · 2 Jan 2016 · Preferential Offer · holds 3,87,378 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Zenlabs Ethica stake sales and purchases
All 20 disclosures on record.
Mar 2024
- AcquiredHitesh Popatlal Oswal6.14% of the company4,00,000 sharesholds 6.79% after22 Mar 2024 · filed under the 5% rule · Off Market
- SoldPreet Remedies Ltd6.14% of the company4,00,000 sharesholds 26.58% after22 Mar 2024 · filed under the 2% rule · Off Market
Nov 2022
- SoldPreet Remedies Ltd · promoter2.44% of the company1,58,860 sharesholds 33.43% after7 Nov 2022 · filed under the 2% rule · Market
Aug 2022
- SoldPreet Remedies Ltd · promoter2.95% of the company1,91,972 sharesholds 35.87% after22 Aug 2022 · filed under the 2% rule · Market
Jun 2022
- SoldPreet Remedies Ltd · promoter2.38% of the company1,55,000 sharesholds 38.82% after17 Jun 2022 · filed under the 2% rule · Market
Nov 2021
- SoldHarpreet Singh Kalra · promoter10.41% of the company6,77,957 shares22 Nov 2021 · filed under the 2% rule · Off Market / Inter se transfer
- AcquiredPreet Remedies Ltd10.41% of the company6,77,957 shares22 Nov 2021 · filed as exempt from an open offer
- AcquiredPreet Remedies Ltd · promoter10.41% of the company6,77,957 sharesholds 41.20% after22 Nov 2021 · filed under the 2% rule · Off Market / Inter se transfer
- ProposedPreet Remedies Ltd · promoter10.41% of the company6,77,957 shares12 Nov 2021 · notice before a transfer exempt from an open offer
Aug 2021
- SoldSatish Kumar (Revised) · promoter5.51% of the company3,59,000 shares11 Aug 2021 · filed under the 2% rule · Off Market / Inter se transfer
- AcquiredSanjay Dhir · promoter2.75% of the company1,79,500 sharesholds 13.17% after11 Aug 2021 · filed under the 2% rule · Inter-se Transfer
- AcquiredSanjeev Kumar & Sanjay Dhir5.51% of the company3,59,000 shares11 Aug 2021 · filed as exempt from an open offer
- AcquiredSanjeev Kumar · promoter2.75% of the company1,79,500 sharesholds 13.17% after11 Aug 2021 · filed under the 2% rule · Inter-se Transfer
Jul 2021
1 entry
- ProposedSanjeev Kumar & Sanjay Dhir · promoter5.51% of the company3,59,000 shares30 Jul 2021 · notice before a transfer exempt from an open offer
Oct 2018
1 entry
- BonusEvery 20 shares became 21 on 11 Oct 2018. The lines below are on the share count before it.
Mar 2017
2 entries
- AcquiredPreet Remedies Pvt Ltd4.83% of the company3,00,000 shares20 Mar 2017 · filed as exempt from an open offer
- AcquiredPreet Remedies Private Limited · promoter4.83% of the company3,00,000 sharesholds 30.84% after20 Mar 2017 · filed under the 2% rule · Off Market / Inter se transfer
Jan 2016
4 entries
- AcquiredSatish Kumar · promoter6.25% of the company3,87,378 sharesholds 32.26% after2 Jan 2016 · filed under the 5% rule · Preferential allotment
- AcquiredHarpreet Singh Karla · promoter11.80% of the company7,31,626 sharesholds 37.81% after2 Jan 2016 · filed under the 5% rule · Preferential allotment
- AcquiredSanjeev Kumar · promoter11.80% of the company7,31,626 sharesholds 37.81% after2 Jan 2016 · filed under the 5% rule · Preferential allotment
- AcquiredSanjay Dhir · promoter11.80% of the company7,31,884 sharesholds 37.81% after2 Jan 2016 · filed under the 5% rule · Preferential allotment
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Zenlabs Ethica bulk deals
Last 12 months, since 30 Oct 2025: 3 bulk deals, ₹0.09 Cr bought and ₹0.21 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 13 Mar 20261 firm · ₹0 bought · ₹0.07 Cr soldNet sold ₹0.07 Cr
- SoldUSHA JAWAHARLAL KALROSold 36,001 at ₹20.200.55% of the company₹0.07 Cr
Monday 15 Dec 20252 firms · ₹0.09 Cr bought · ₹0.13 Cr soldNet sold ₹0.04 Cr
- SoldSHYAMA GOYALSold 60,000 at ₹22.060.92% of the company₹0.13 Cr
- BoughtKAMAL KUMAR GOYALBought 40,000 at ₹22.030.61% of the company₹0.09 Cr
Wednesday 16 Jul 20252 firms · ₹0.13 Cr bought · ₹0.27 Cr soldNet sold ₹0.13 Cr
- SoldRAJESH KUMARSold 35,604 at ₹35.920.55% of the company₹0.13 Cr
- Both waysUSHA JAWAHARLAL KALROBought 37,301 at ₹35.91Sold 38,696 at ₹36.450.59% of the companyNet −1,395 shares₹0.13 Cr bought
Friday 21 Mar 20252 firms · ₹0.14 Cr bought · ₹0.14 Cr soldNet nil
- Both waysUSHA JAWAHARLAL KALROBought 43,854 at ₹30.99Sold 6,500 at ₹31.860.67% of the companyNet +37,354 shares₹0.14 Cr bought
- SoldHITESH BASANT SUNDESHASold 36,972 at ₹30.990.57% of the company₹0.11 Cr
Thursday 20 Mar 20251 firm · ₹0.11 Cr bought · ₹0 soldNet bought ₹0.11 Cr
- BoughtHITESH BASANT SUNDESHABought 36,972 at ₹31.030.57% of the company₹0.11 Cr
Thursday 10 Oct 20241 firm · ₹0 bought · ₹0.19 Cr soldNet sold ₹0.19 Cr
- SoldHARISH KUMARSold 46,100 at ₹40.960.71% of the company₹0.19 Cr
Friday 24 Feb 20231 firm · ₹0.20 Cr bought · ₹0 soldNet bought ₹0.20 Cr
- BoughtRAKESH KUMAR ARORABought 32,633 at ₹61.280.50% of the company₹0.20 Cr
Wednesday 9 Nov 20222 firms · ₹0.41 Cr bought · ₹0.35 Cr soldNet bought ₹0.06 Cr
- BoughtABHIK NARENDRABHAI PATELBought 53,000 at ₹76.440.81% of the company₹0.41 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 45,473 at ₹76.450.70% of the company₹0.35 Cr
Monday 7 Nov 20221 firm · ₹0 bought · ₹0.26 Cr soldNet sold ₹0.26 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 35,000 at ₹75.450.54% of the company₹0.26 Cr
Tuesday 30 Aug 20222 firms · ₹0.20 Cr bought · ₹0.28 Cr soldNet sold ₹0.08 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 40,000 at ₹56.020.61% of the company₹0.22 Cr
- Both waysABHIK NARENDRABHAI PATELBought 35,000 at ₹56.03Sold 10,000 at ₹55.920.54% of the companyNet +25,000 shares₹0.20 Cr bought
Wednesday 29 Jun 20222 firms · ₹0.16 Cr bought · ₹0.45 Cr soldNet sold ₹0.29 Cr
- SoldGOPAL ROY CHOUDHURYSold 70,756 at ₹41.211.09% of the company₹0.29 Cr
- Both waysUSHA JAWAHARLAL KALROBought 38,053 at ₹41.71Sold 38,656 at ₹40.920.59% of the companyNet −603 shares₹0.16 Cr bought
Monday 27 Jun 20221 firm · ₹0 bought · ₹0.25 Cr soldNet sold ₹0.25 Cr
- SoldPARUL DASSold 55,671 at ₹45.400.86% of the company₹0.25 Cr
Friday 24 Jun 20221 firm · ₹0 bought · ₹0.24 Cr soldNet sold ₹0.24 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 50,000 at ₹48.200.77% of the company₹0.24 Cr
Thursday 23 Jun 20221 firm · ₹0 bought · ₹0.21 Cr soldNet sold ₹0.21 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 50,000 at ₹42.100.77% of the company₹0.21 Cr
Friday 17 Jun 20221 firm · ₹0 bought · ₹0.19 Cr soldNet sold ₹0.19 Cr
- SoldPREET REMEDIES PRIVATE LIMITESold 50,000 at ₹38.500.77% of the company₹0.19 Cr
Wednesday 18 May 20221 firm · ₹0.01 Cr bought · ₹0.12 Cr soldNet sold ₹0.11 Cr
- Both waysCHETAN BALUBHAI PATELBought 3,803 at ₹31.33Sold 36,000 at ₹32.710.55% of the companyNet −32,197 shares₹0.01 Cr bought
Thursday 21 Oct 20212 firms · ₹0.12 Cr bought · ₹0.28 Cr soldNet sold ₹0.17 Cr
- SoldMULTIBAGGER SECURITIES RESEARCH ADVISORY PRIVATE LIMITEDSold 50,000 at ₹33.080.77% of the company₹0.17 Cr
- Both waysUSHA JAWAHARLAL KALROBought 35,502 at ₹33.02Sold 35,502 at ₹33.670.55% of the companyNet nil₹0.12 Cr bought
Friday 23 Jul 20211 firm · ₹0.38 Cr bought · ₹0.30 Cr soldNet bought ₹0.08 Cr
- Both waysUSHA JAWAHARLAL KALROBought 79,726 at ₹47.28Sold 62,880 at ₹47.841.22% of the companyNet +16,846 shares₹0.38 Cr bought
Friday 2 Jul 20211 firm · ₹0.14 Cr bought · ₹0.15 Cr soldNet sold ₹89,917
- Both waysUSHA JAWAHARLAL KALROBought 33,551 at ₹41.14Sold 33,551 at ₹43.820.52% of the companyNet nil₹0.14 Cr bought
Wednesday 10 Mar 20211 firm · ₹0 bought · ₹0.09 Cr soldNet sold ₹0.09 Cr
- SoldMEHARDEEP SINGHSold 43,000 at ₹21.110.66% of the company₹0.09 Cr
Friday 3 May 20192 firms · ₹0.15 Cr bought · ₹0.19 Cr soldNet sold ₹0.05 Cr
- SoldC GAUTAM GANESHSold 42,699 at ₹44.110.66% of the company₹0.19 Cr
- Both waysALPHA LEON ENTERPRISES LLPBought 33,001 at ₹44.00Sold 1,101 at ₹45.680.51% of the companyNet +31,900 shares₹0.15 Cr bought
BonusEvery 20 shares became 21 on 11 Oct 2018. The lines below are on the share count before it.
Wednesday 1 Aug 20181 firm · ₹0 bought · ₹0.30 Cr soldNet sold ₹0.30 Cr
- SoldAZMATULLAH MOHAMMEDSold 49,700 at ₹59.880.80% of the company₹0.30 Cr
Monday 16 Jul 20182 firms · ₹0.23 Cr bought · ₹0.31 Cr soldNet sold ₹0.07 Cr
- SoldGUTTIKONDA VARA LAKSHMISold 65,641 at ₹46.521.06% of the company₹0.31 Cr
- BoughtPARUL DASBought 49,925 at ₹46.300.81% of the company₹0.23 Cr
Monday 12 Mar 20182 firms · ₹0.22 Cr bought · ₹0.22 Cr soldNet nil
- SoldBRIJKISHOR KISHANGOPAL SONISold 40,000 at ₹56.110.65% of the company₹0.22 Cr
- BoughtINFOTREK SYSCOM LIMITEDBought 40,000 at ₹56.110.65% of the company₹0.22 Cr
Monday 17 Apr 20171 firm · ₹0.25 Cr bought · ₹0 soldNet bought ₹0.25 Cr
- BoughtGUTTIKONDA VARA LAKSHMIBought 50,000 at ₹50.200.81% of the company₹0.25 Cr
Tuesday 9 Feb 20161 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldBHAWARSINGH VAKTAVARSINGH RAJPUROHITSold 20,400 at ₹15.000.56% of the company₹0.03 Cr
Friday 15 Jan 20161 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldBP FINTRADE PRIVATE LIMITEDSold 20,000 at ₹15.000.55% of the company₹0.03 Cr
Tuesday 27 Apr 20101 firm · ₹0.08 Cr bought · ₹0 soldNet bought ₹0.08 Cr
- BoughtSUBHASH AGARWAL HUFBought 23,000 at ₹34.45₹0.08 Cr
Friday 23 Apr 20101 firm · ₹0.08 Cr bought · ₹0 soldNet bought ₹0.08 Cr
- BoughtNISHASUBHASH AGARWALBought 25,000 at ₹31.30₹0.08 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 47 deals on record from 4 Jan 2004.